SARS-CoV-2 Spike Glycoprotein RBD Antibody

Product Graph
481€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
SARS-CoV-2 Spike Glycoprotein RBD Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx243130
tested applications
ELISA

Description

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Glycoprotein Receptor-Binding Domain Protein Nanobody is a recombinant monoclonal antibody expressed in HEK293 cells for the detection of SARS-CoV-2/COVID-19 S RBD Protein. This antibody contains V

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: SARS-CoV-2 Spike Glycoprotein
Immunogen: abx600065 - Recombinant SARS-CoV-2 S protein (319-514 AA) expressed in Mammalian cells.
Reactivity
Virus
Recommended Dilution
ELISA: 1/10000 - 1/100000, LF (GICA): 1/10000 - 1/40000, Neutralization: 1/100 - 1/10000. Optimal dilutions/concentrations should be determined by the end user.
Origin
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG1
Expression
Recombinant
Purification
Purified by affinity chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P0DTC2
Gene ID
43740568
Background
Antibody anti-SARS CoV-2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Related Products

abx600065

SARS-CoV-2 Spike Glycoprotein

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19/2019-nCoV) Spike Glycoprotein is a recombinant protein expressed in Mammalian cells.

Ver Producto